U.S. Food and Drug Administration (FDA) · United States

FDA Weight Loss Product Labeling and Safety Standards

Weight-loss product marketing must avoid unrealistic or drug-equivalent claims and banned ingredients, disclose typical results for testimonials, and carry Supplement Facts and the DSHEA disclaimer on labeling.

21 U.S.C. 342(f)(1)(A), 343(a)(1), 343(r)(6); 21 CFR 101.36(a), (e)(1); 21 CFR 101.93(c), (d), (f), (g)(2); 21 CFR 119.1; 15 U.S.C. 45(a)(1), 52(a)-(b); 16 CFR 255.2(a)-(b)

What is FDA Weight Loss Product Labeling and Safety Standards?

Weight-loss product marketing must avoid unrealistic or drug-equivalent claims and banned ingredients, disclose typical results for testimonials, and carry Supplement Facts and the DSHEA disclaimer on labeling. Apply to US weight-loss supplement, OTC and meal-replacement marketing in any channel. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers · Dietary Supplement, OTC Drug · supplements cosmetics

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Weight-loss product marketing must avoid unrealistic or drug-equivalent claims and banned ingredients, disclose typical results for testimonials, and carry Supplement Facts and the DSHEA disclaimer on labeling.

How can marketing teams comply?

Apply to US weight-loss supplement, OTC and meal-replacement marketing in any channel.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 342(f)(1)(A), 343(a)(1), 343(r)(6); 21 CFR 101.36(a), (e)(1); 21 CFR 101.93(c), (d), (f), (g)(2); 21 CFR 119.1; 15 U.S.C. 45(a)(1), 52(a)-(b); 16 CFR 255.2(a)-(b)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
Dietary Supplement, OTC Drug
Audiences
general_audience, general_adults_18plus, customers

Frequently asked questions

What is FDA Weight Loss Product Labeling and Safety Standards?

Weight-loss product marketing must avoid unrealistic or drug-equivalent claims and banned ingredients, disclose typical results for testimonials, and carry Supplement Facts and the DSHEA disclaimer on labeling.

Who does this rule apply to?

general_audience, general_adults_18plus, customers · Dietary Supplement, OTC Drug · supplements cosmetics

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan